Europe Pneumonia Vaccines Market (2019-2025)
The Europe Pneumonia Vaccines Market would witness market growth of 4.5% CAGR during the forecast period (2019–2025).
Pneumococcal diseases are most common in younger children; however, adults and the elderly population are also prone to pneumococcal contaminations that lead to death as well. Pneumonia vaccines are primarily given to the children less than 2 years and to the adults of 65 years and older. These vaccines help to provide immunization against 13 types of pneumococcal bacteria that cause infection in the lungs. Increasing government support in creating awareness regarding pneumonia immunization programs, rising prevalence of pneumococcal contaminations within the population, and introduction of novel pneumococcal vaccines are some of the major factors driving the growth of the global pneumonia vaccine market. However, longer timelines required for the production of pneumococcal vaccines and higher costs associated with the development of the vaccines are hindering the growth of the market.
Based on Vaccine Type, the market is segmented into Pneumococcal conjugate vaccine (PCV) and Pneumococcal polysaccharide vaccine (PPSV/PPV). Based on Product Type, the market is segmented into Prevnar 13, Synflorix and Pneumovax23. According to sector, the market is segmented into Public sector and Private sector. Based on Distribution Channel, the market is further segmented into Distribution partner companies, Non-governmental Organizations (NGO) and Government Authorities. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Glaxosmithkline Plc. (GSK), LG Corporation, Panacea Biotec Limited, Pfizer, Inc., Pnuvax Incorporated, Poonawalla Investments & Industries Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Holdings Co., Ltd., Walvax Biotechnology Co., Ltd. and MERCK & CO., Inc.
Scope of the Study
Market Segmentation:
By Vaccine Type
Pneumococcal diseases are most common in younger children; however, adults and the elderly population are also prone to pneumococcal contaminations that lead to death as well. Pneumonia vaccines are primarily given to the children less than 2 years and to the adults of 65 years and older. These vaccines help to provide immunization against 13 types of pneumococcal bacteria that cause infection in the lungs. Increasing government support in creating awareness regarding pneumonia immunization programs, rising prevalence of pneumococcal contaminations within the population, and introduction of novel pneumococcal vaccines are some of the major factors driving the growth of the global pneumonia vaccine market. However, longer timelines required for the production of pneumococcal vaccines and higher costs associated with the development of the vaccines are hindering the growth of the market.
Based on Vaccine Type, the market is segmented into Pneumococcal conjugate vaccine (PCV) and Pneumococcal polysaccharide vaccine (PPSV/PPV). Based on Product Type, the market is segmented into Prevnar 13, Synflorix and Pneumovax23. According to sector, the market is segmented into Public sector and Private sector. Based on Distribution Channel, the market is further segmented into Distribution partner companies, Non-governmental Organizations (NGO) and Government Authorities. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Glaxosmithkline Plc. (GSK), LG Corporation, Panacea Biotec Limited, Pfizer, Inc., Pnuvax Incorporated, Poonawalla Investments & Industries Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Holdings Co., Ltd., Walvax Biotechnology Co., Ltd. and MERCK & CO., Inc.
Scope of the Study
Market Segmentation:
By Vaccine Type
- Pneumococcal conjugate vaccine (PCV)
- Pneumococcal polysaccharide vaccine (PPSV/PPV)
- Prevnar 13
- Synflorix
- Pneumovax23
- Public sector
- Private sector
- Distribution partner companies
- Non-governmental Organizations (NGO)
- Government Authorities
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Glaxosmithkline Plc. (GSK)
- LG Corporation
- Panacea Biotec Limited
- Pfizer, Inc.
- Pnuvax Incorporated
- Poonawalla Investments & Industries Pvt. Ltd.
- Shenzhen Kangtai Biological Products Co., Ltd.
- SK Holdings Co., Ltd.
- Walvax Biotechnology Co., Ltd.
- Merck & Co., Inc.
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Pneumonia Vaccines Market, by Vaccine Type
1.4.2 Europe Pneumonia Vaccines Market, by Product Type
1.4.3 Europe Pneumonia Vaccines Market, by Sector
1.4.4 Europe Pneumonia Vaccines Market, by Distribution Channel
1.4.5 Europe Pneumonia Vaccines Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE PNEUMONIA VACCINES MARKET BY VACCINE TYPE
3.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market by Region
3.2 Europe Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
CHAPTER 4. EUROPE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE
4.1 Europe Prevnar 13 Market by Region
4.2 Europe Synflorix Market by Region
4.3 Europe Pneumovax 23 Market by Region
CHAPTER 5. EUROPE PNEUMONIA VACCINES MARKET BY SECTOR
5.1 Europe Private sector Market by Region
5.2 Europe Public sector Market by Region
5.2.1 Europe Pneumonia Vaccines Market by Distribution Channel
5.3 Europe Distribution Partner Companies Market by Region
5.4 Europe Non-Governmental Organizations (NGO) Market by Region
5.5 Europe Government Authorities Market by Region
CHAPTER 6. EUROPE PNEUMONIA VACCINES MARKET BY COUNTRY
6.1 Germany Pneumonia Vaccines Market
6.1.1 Germany Pneumonia Vaccines Market by Vaccine Type
6.1.2 Germany Pneumonia Vaccines Market by Product Type
6.1.3 Germany Pneumonia Vaccines Market by Sector
6.1.4 Germany Pneumonia Vaccines Market by Distribution Channel
6.2 UK Pneumonia Vaccines Market
6.2.1 UK Pneumonia Vaccines Market by Vaccine Type
6.2.2 UK Pneumonia Vaccines Market by Product Type
6.2.3 UK Pneumonia Vaccines Market by Sector
6.2.4 UK Pneumonia Vaccines Market by Distribution Channel
6.3 France Pneumonia Vaccines Market
6.3.1 France Pneumonia Vaccines Market by Vaccine Type
6.3.2 France Pneumonia Vaccines Market by Product Type
6.3.3 France Pneumonia Vaccines Market by Sector
6.3.4 France Pneumonia Vaccines Market by Distribution Channel
6.4 Russia Pneumonia Vaccines Market
6.4.1 Russia Pneumonia Vaccines Market by Vaccine Type
6.4.2 Russia Pneumonia Vaccines Market by Product Type
6.4.3 Russia Pneumonia Vaccines Market by Sector
6.4.4 Russia Pneumonia Vaccines Market by Distribution Channel
6.5 Spain Pneumonia Vaccines Market
6.5.1 Spain Pneumonia Vaccines Market by Vaccine Type
6.5.2 Spain Pneumonia Vaccines Market by Product Type
6.5.3 Spain Pneumonia Vaccines Market by Sector
6.5.4 Spain Pneumonia Vaccines Market by Distribution Channel
6.6 Italy Pneumonia Vaccines Market
6.6.1.1.1 Italy Pneumonia Vaccines Market by Vaccine Type
6.6.2 Italy Pneumonia Vaccines Market by Product Type
6.6.3 Italy Pneumonia Vaccines Market by Sector
6.6.4 Italy Pneumonia Vaccines Market by Distribution Channel
6.7 Rest of Europe Pneumonia Vaccines Market
6.7.1 Rest of Europe Pneumonia Vaccines Market by Vaccine Type
6.7.2 Rest of Europe Pneumonia Vaccines Market by Product Type
6.7.3 Rest of Europe Pneumonia Vaccines Market by Sector
6.7.4 Rest of Europe Pneumonia Vaccines Market by Distribution Channel
CHAPTER 7. COMPANY PROFILES
7.1 GLAXOSMITHKLINE PLC (GSK)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.1 Recent strategies and developments:
7.1.1.1 Collaboration, partnerships and agreements:
7.1.1.2 Expansion:
7.1.2 SWOT Analysis
7.2 LG Corporation (LG Chemicals Ltd.)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Panacea Biotec Limited
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Collaboration, partnerships and agreements:
7.3.6 SWOT Analysis
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Collaboration, partnerships and agreements:
7.4.5.2 Product launch:
7.4.6 SWOT Analysis
7.5 PnuVax Incorporated
7.5.1 Company Overview
7.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
7.6.1 Company Overview
7.7 Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
7.7.1 Company Overview
7.8 SK Holdings Co., Ltd. (SK Bioscience, Inc.)
7.8.1 Company overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.9 Walvax Biotechnology Co., Ltd.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Product launch:
7.1 Merck & Co., Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Collaboration, partnerships and agreements:
7.10.5.2 Product launch:
7.10.6 SWOT Analysis
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Pneumonia Vaccines Market, by Vaccine Type
1.4.2 Europe Pneumonia Vaccines Market, by Product Type
1.4.3 Europe Pneumonia Vaccines Market, by Sector
1.4.4 Europe Pneumonia Vaccines Market, by Distribution Channel
1.4.5 Europe Pneumonia Vaccines Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE PNEUMONIA VACCINES MARKET BY VACCINE TYPE
3.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market by Region
3.2 Europe Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
CHAPTER 4. EUROPE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE
4.1 Europe Prevnar 13 Market by Region
4.2 Europe Synflorix Market by Region
4.3 Europe Pneumovax 23 Market by Region
CHAPTER 5. EUROPE PNEUMONIA VACCINES MARKET BY SECTOR
5.1 Europe Private sector Market by Region
5.2 Europe Public sector Market by Region
5.2.1 Europe Pneumonia Vaccines Market by Distribution Channel
5.3 Europe Distribution Partner Companies Market by Region
5.4 Europe Non-Governmental Organizations (NGO) Market by Region
5.5 Europe Government Authorities Market by Region
CHAPTER 6. EUROPE PNEUMONIA VACCINES MARKET BY COUNTRY
6.1 Germany Pneumonia Vaccines Market
6.1.1 Germany Pneumonia Vaccines Market by Vaccine Type
6.1.2 Germany Pneumonia Vaccines Market by Product Type
6.1.3 Germany Pneumonia Vaccines Market by Sector
6.1.4 Germany Pneumonia Vaccines Market by Distribution Channel
6.2 UK Pneumonia Vaccines Market
6.2.1 UK Pneumonia Vaccines Market by Vaccine Type
6.2.2 UK Pneumonia Vaccines Market by Product Type
6.2.3 UK Pneumonia Vaccines Market by Sector
6.2.4 UK Pneumonia Vaccines Market by Distribution Channel
6.3 France Pneumonia Vaccines Market
6.3.1 France Pneumonia Vaccines Market by Vaccine Type
6.3.2 France Pneumonia Vaccines Market by Product Type
6.3.3 France Pneumonia Vaccines Market by Sector
6.3.4 France Pneumonia Vaccines Market by Distribution Channel
6.4 Russia Pneumonia Vaccines Market
6.4.1 Russia Pneumonia Vaccines Market by Vaccine Type
6.4.2 Russia Pneumonia Vaccines Market by Product Type
6.4.3 Russia Pneumonia Vaccines Market by Sector
6.4.4 Russia Pneumonia Vaccines Market by Distribution Channel
6.5 Spain Pneumonia Vaccines Market
6.5.1 Spain Pneumonia Vaccines Market by Vaccine Type
6.5.2 Spain Pneumonia Vaccines Market by Product Type
6.5.3 Spain Pneumonia Vaccines Market by Sector
6.5.4 Spain Pneumonia Vaccines Market by Distribution Channel
6.6 Italy Pneumonia Vaccines Market
6.6.1.1.1 Italy Pneumonia Vaccines Market by Vaccine Type
6.6.2 Italy Pneumonia Vaccines Market by Product Type
6.6.3 Italy Pneumonia Vaccines Market by Sector
6.6.4 Italy Pneumonia Vaccines Market by Distribution Channel
6.7 Rest of Europe Pneumonia Vaccines Market
6.7.1 Rest of Europe Pneumonia Vaccines Market by Vaccine Type
6.7.2 Rest of Europe Pneumonia Vaccines Market by Product Type
6.7.3 Rest of Europe Pneumonia Vaccines Market by Sector
6.7.4 Rest of Europe Pneumonia Vaccines Market by Distribution Channel
CHAPTER 7. COMPANY PROFILES
7.1 GLAXOSMITHKLINE PLC (GSK)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.1 Recent strategies and developments:
7.1.1.1 Collaboration, partnerships and agreements:
7.1.1.2 Expansion:
7.1.2 SWOT Analysis
7.2 LG Corporation (LG Chemicals Ltd.)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Panacea Biotec Limited
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Collaboration, partnerships and agreements:
7.3.6 SWOT Analysis
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Collaboration, partnerships and agreements:
7.4.5.2 Product launch:
7.4.6 SWOT Analysis
7.5 PnuVax Incorporated
7.5.1 Company Overview
7.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
7.6.1 Company Overview
7.7 Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
7.7.1 Company Overview
7.8 SK Holdings Co., Ltd. (SK Bioscience, Inc.)
7.8.1 Company overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.9 Walvax Biotechnology Co., Ltd.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Product launch:
7.1 Merck & Co., Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Collaboration, partnerships and agreements:
7.10.5.2 Product launch:
7.10.6 SWOT Analysis
LIST OF TABLES
TABLE 1 EUROPE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 3 EUROPE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 4 EUROPE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 5 EUROPE PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 6 EUROPE PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 7 EUROPE PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 8 EUROPE PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 9 EUROPE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 10 EUROPE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 11 EUROPE PREVNAR 13 MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 12 EUROPE PREVNAR 13 MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 13 EUROPE SYNFLORIX MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 14 EUROPE SYNFLORIX MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 15 EUROPE PNEUMOVAX 23 MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 16 EUROPE PNEUMOVAX 23 MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 17 EUROPE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 18 EUROPE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 19 EUROPE PRIVATE SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 20 EUROPE PRIVATE SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 21 EUROPE PUBLIC SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 22 EUROPE PUBLIC SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 23 EUROPE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 EUROPE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 EUROPE DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 26 EUROPE DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 27 EUROPE NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 28 EUROPE NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 29 EUROPE GOVERNMENT AUTHORITIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 30 EUROPE GOVERNMENT AUTHORITIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 31 EUROPE PNEUMONIA VACCINES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 32 EUROPE PNEUMONIA VACCINES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 33 GERMANY PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 34 GERMANY PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 35 GERMANY PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 36 GERMANY PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 37 GERMANY PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 38 GERMANY PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 39 GERMANY PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 40 GERMANY PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 41 GERMANY PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 42 GERMANY PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 43 UK PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 44 UK PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 45 UK PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 46 UK PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 47 UK PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 48 UK PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 49 UK PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 50 UK PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 51 UK PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 52 UK PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 53 FRANCE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 54 FRANCE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 55 FRANCE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 56 FRANCE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 57 FRANCE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 58 FRANCE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 59 FRANCE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 60 FRANCE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 61 FRANCE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 62 FRANCE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 63 RUSSIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 64 RUSSIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 65 RUSSIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 66 RUSSIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 67 RUSSIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 68 RUSSIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 69 RUSSIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 70 RUSSIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 71 RUSSIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 72 RUSSIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 73 SPAIN PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 74 SPAIN PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 75 SPAIN PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 76 SPAIN PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 77 SPAIN PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 78 SPAIN PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 79 SPAIN PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 80 SPAIN PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 81 SPAIN PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 82 SPAIN PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 83 ITALY PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 84 ITALY PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 85 ITALY PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 86 ITALY PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 87 ITALY PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 88 ITALY PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 89 ITALY PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 90 ITALY PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 91 ITALY PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 92 ITALY PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 93 REST OF EUROPE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 94 REST OF EUROPE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 95 REST OF EUROPE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 96 REST OF EUROPE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 97 REST OF EUROPE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 98 REST OF EUROPE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 99 REST OF EUROPE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 100 REST OF EUROPE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 101 REST OF EUROPE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 102 REST OF EUROPE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 103 KEY INFORMATION – GLAXOSMITHKLINE PLC (GSK)
TABLE 104 KEY INFORMATION – LG CORPORATION
TABLE 105 KEY INFORMATION – PANACEA BIOTEC LIMITED
TABLE 106 KEY INFORMATION – PFIZER, INC.
TABLE 107 KEY INFORMATION – PNUVAX INCORPORATED
TABLE 108 KEY INFORMATION – POONAWALLA INVESTMENTS & INDUSTRIES PVT. LTD.
TABLE 109 KEY INFORMATION – SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
TABLE 110 KEY INFORMATION – SK HOLDINGS CO., LTD.
TABLE 111 KEY INFORMATION – WALVAX BIOTECHNOLOGY CO., LTD.
TABLE 112 KEY INFORMATION - MERCK & CO., INC.
TABLE 1 EUROPE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 3 EUROPE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 4 EUROPE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 5 EUROPE PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 6 EUROPE PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 7 EUROPE PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 8 EUROPE PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 9 EUROPE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 10 EUROPE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 11 EUROPE PREVNAR 13 MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 12 EUROPE PREVNAR 13 MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 13 EUROPE SYNFLORIX MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 14 EUROPE SYNFLORIX MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 15 EUROPE PNEUMOVAX 23 MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 16 EUROPE PNEUMOVAX 23 MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 17 EUROPE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 18 EUROPE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 19 EUROPE PRIVATE SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 20 EUROPE PRIVATE SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 21 EUROPE PUBLIC SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 22 EUROPE PUBLIC SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 23 EUROPE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 EUROPE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 EUROPE DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 26 EUROPE DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 27 EUROPE NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 28 EUROPE NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 29 EUROPE GOVERNMENT AUTHORITIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 30 EUROPE GOVERNMENT AUTHORITIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 31 EUROPE PNEUMONIA VACCINES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 32 EUROPE PNEUMONIA VACCINES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 33 GERMANY PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 34 GERMANY PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 35 GERMANY PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 36 GERMANY PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 37 GERMANY PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 38 GERMANY PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 39 GERMANY PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 40 GERMANY PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 41 GERMANY PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 42 GERMANY PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 43 UK PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 44 UK PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 45 UK PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 46 UK PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 47 UK PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 48 UK PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 49 UK PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 50 UK PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 51 UK PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 52 UK PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 53 FRANCE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 54 FRANCE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 55 FRANCE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 56 FRANCE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 57 FRANCE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 58 FRANCE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 59 FRANCE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 60 FRANCE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 61 FRANCE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 62 FRANCE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 63 RUSSIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 64 RUSSIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 65 RUSSIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 66 RUSSIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 67 RUSSIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 68 RUSSIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 69 RUSSIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 70 RUSSIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 71 RUSSIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 72 RUSSIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 73 SPAIN PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 74 SPAIN PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 75 SPAIN PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 76 SPAIN PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 77 SPAIN PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 78 SPAIN PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 79 SPAIN PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 80 SPAIN PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 81 SPAIN PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 82 SPAIN PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 83 ITALY PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 84 ITALY PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 85 ITALY PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 86 ITALY PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 87 ITALY PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 88 ITALY PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 89 ITALY PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 90 ITALY PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 91 ITALY PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 92 ITALY PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 93 REST OF EUROPE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 94 REST OF EUROPE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 95 REST OF EUROPE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 96 REST OF EUROPE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 97 REST OF EUROPE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 98 REST OF EUROPE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 99 REST OF EUROPE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 100 REST OF EUROPE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 101 REST OF EUROPE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 102 REST OF EUROPE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 103 KEY INFORMATION – GLAXOSMITHKLINE PLC (GSK)
TABLE 104 KEY INFORMATION – LG CORPORATION
TABLE 105 KEY INFORMATION – PANACEA BIOTEC LIMITED
TABLE 106 KEY INFORMATION – PFIZER, INC.
TABLE 107 KEY INFORMATION – PNUVAX INCORPORATED
TABLE 108 KEY INFORMATION – POONAWALLA INVESTMENTS & INDUSTRIES PVT. LTD.
TABLE 109 KEY INFORMATION – SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
TABLE 110 KEY INFORMATION – SK HOLDINGS CO., LTD.
TABLE 111 KEY INFORMATION – WALVAX BIOTECHNOLOGY CO., LTD.
TABLE 112 KEY INFORMATION - MERCK & CO., INC.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
